Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Rheumatoid Arthritis

  Free Subscription


Articles published in J Rheumatol

Retrieve available abstracts of 178 articles:
HTML format



Single Articles


    July 2024
  1. NIKOLIC RPA, Pardo Pardo J, Pope JE, Barber CEH, et al
    Canadian Rheumatology Association Living Guidelines for Rheumatoid Arthritis: Update #2.
    J Rheumatol. 2024 Jul 15:jrheum.2024-0540. doi: 10.3899/jrheum.2024-0540.
    PubMed     Abstract available


  2. EL-GABALAWY H
    The Impact of Rheumatoid Arthritis on First Nations and How We Can Work With Communities to Prevent It.
    J Rheumatol. 2024;51.
    PubMed     Abstract available


  3. TAYLOR PC
    The Rheumatoid Arthritis Impact of Disease (RAID) Score in Telemedicine Management of Rheumatoid Arthritis.
    J Rheumatol. 2024 Jul 1:jrheum.2024-0579. doi: 10.3899/jrheum.2024-0579.
    PubMed     Abstract available


  4. VASSILAKI M, Jose George R, Kumar R, Lovering E, et al
    Validation of Different Dementia Code-based Definitions in a Population-based Study of Rheumatoid Arthritis.
    J Rheumatol. 2024 Jul 1:jrheum.2024-0299. doi: 10.3899/jrheum.2024-0299.
    PubMed     Abstract available


  5. TARANNUM S, Widdifield J, Wu CF, Johnson SR, et al
    Sex-Related Differences in Dispensation of Rheumatic Medications in Older Patients With Inflammatory Arthritis: A Population-Based Study.
    J Rheumatol. 2024;51:703-707.
    PubMed     Abstract available


  6. VISSER A, van Nimwegen JF, Wilbrink R, Liefers SC, et al
    Increased Interferon Signaling in Vaginal Tissue of Patients With Primary Sjogren Syndrome.
    J Rheumatol. 2024;51:687-695.
    PubMed     Abstract available


    June 2024
  7. WEBER BN, Weisenfeld D, Jeffway M, Liu F, et al
    The Association Between High-Sensitivity Cardiac Troponin T and Major Adverse Cardiovascular Events in Rheumatoid Arthritis.
    J Rheumatol. 2024 Jun 15:jrheum.2024-0168. doi: 10.3899/jrheum.2024-0168.
    PubMed     Abstract available


  8. AVOUAC J, Molto A, Allanore Y
    Evaluation of the RAID Score in Assessing Rheumatoid Arthritis Activity in Teleconsultation.
    J Rheumatol. 2024 Jun 1:jrheum.2024-0143. doi: 10.3899/jrheum.2024-0143.
    PubMed     Abstract available


  9. SUBDAR S, Dhiman K, Hartfeld NMS, Hoens AM, et al
    Investigating the Influence of Patient Eligibility Characteristics on the Number of Deferrable Rheumatologist Visits: Planning for a Patient-Initiated Follow-Up Strategy.
    J Rheumatol. 2024;51:587-595.
    PubMed     Abstract available


    May 2024
  10. SMITH ID, Solomon MJ, Mulder H, Sims C, et al
    Evaluating factors associated with telehealth appropriateness in outpatient rheumatoid arthritis encounters using the Encounter Appropriateness Score for You (EASY).
    J Rheumatol. 2024 May 15:jrheum.2024-0014. doi: 10.3899/jrheum.2024-0014.
    PubMed     Abstract available


  11. ORMSETH MJ, Oeser AM, Chung CP, Stein CM, et al
    Ambulatory blood pressure in patients with rheumatoid arthritis: association with immune activation.
    J Rheumatol. 2024 May 15:jrheum.2024-0205. doi: 10.3899/jrheum.2024-0205.
    PubMed     Abstract available


  12. RYDELL E, Jacobsson LTH, Turesson C
    Circulating interleukin 17A and other inflammatory proteins may predict cardiovascular disease in early rheumatoid arthritis.
    J Rheumatol. 2024 May 1:jrheum.2023-1078. doi: 10.3899/jrheum.2023-1078.
    PubMed     Abstract available


  13. EL-GABALAWY H
    The Impact of Rheumatoid Arthritis on First Nations and How We Can Work With Communities to Prevent It.
    J Rheumatol. 2024 May 1:jrheum.2024-0369. doi: 10.3899/jrheum.2024-0369.
    PubMed     Abstract available


  14. MITTINTY MM, Mittinty MN, Buchbinder R, Lassere M, et al
    Interpersonal process of dyadic coping in rheumatoid arthritis: a perspective from the Australian Rheumatology Association Database (ARAD).
    J Rheumatol. 2024 May 1:jrheum.2023-0664. doi: 10.3899/jrheum.2023-0664.
    PubMed     Abstract available


  15. RUSCITTI P, McGonagle D, Garcia VC, Rabijns H, et al
    Systematic Review and Metaanalysis of Pharmacological Interventions in Adult-Onset Still Disease and the Role of Biologic Disease-Modifying Antirheumatic Drugs.
    J Rheumatol. 2024;51:442-451.
    PubMed     Abstract available


    April 2024
  16. BURMESTER GR, Van den Bosch F, Tesser J, Shmagel A, et al
    Upadacitinib in Rheumatoid Arthritis and Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs: Efficacy and Safety Through 5 Years (SELECT-NEXT).
    J Rheumatol. 2024 Apr 15:jrheum.2023-1062. doi: 10.3899/jrheum.2023-1062.
    PubMed     Abstract available


  17. RAMSAY D, Taylor T
    Does Changing Anticyclic Citrullinated Protein Testing From Restricted Ordering to Open Ordering Affect Healthcare Utilization and the Rate of Positive Testing?
    J Rheumatol. 2024;51:432-433.
    PubMed    


  18. EVIATAR T, Furer V, Polachek A, Zisman D, et al
    Effect of Secukinumab and Tumor Necrosis Factor Inhibitors on Humoral Response to BNT162b2 mRNA Vaccine in Patients With Spondyloarthritis Compared to Immunocompetent Controls.
    J Rheumatol. 2024;51:415-422.
    PubMed     Abstract available


    March 2024
  19. SUBDAR S, Hoens AM, White K, Hartfeld NMS, et al
    An environmental scan and appraisal of patient online resources for managing rheumatoid arthritis flares.
    J Rheumatol. 2024 Mar 15:jrheum.2023-1025. doi: 10.3899/jrheum.2023-1025.
    PubMed     Abstract available


  20. WIENS D, Smolik IA, MacKay D, Fowler-Woods A, et al
    Perceived Access to Health Care of Indigenous Peoples in Canada with Rheumatoid Arthritis and their First-Degree Relatives.
    J Rheumatol. 2024 Mar 1:jrheum.2023-1080. doi: 10.3899/jrheum.2023-1080.
    PubMed     Abstract available


  21. FONG KTD, Sng WJ, Lee KMV, Tan HSA, et al
    A Familiar Face in an Unfamiliar Place: Intraosseous Rheumatoid Nodule.
    J Rheumatol. 2024;51:314-315.
    PubMed    


    February 2024
  22. PAPPAS DA, O'Brien J, Moore PC, Dodge R, et al
    Treatment Patterns and Effectiveness of Tofacitinib in Patients Initiating Therapy for Rheumatoid Arthritis: Results from the CorEvitas Rheumatoid Arthritis Registry.
    J Rheumatol. 2024 Feb 15:jrheum.2023-0752. doi: 10.3899/jrheum.2023-0752.
    PubMed     Abstract available


  23. WIERCZEIKO A, Linke M, Friedrich JP, Koch J, et al
    A Call for Gene Expression Analysis in Whole Blood of Patients With Rheumatoid Arthritis (RA) as a Biomarker for RA-Associated Interstitial Lung Disease.
    J Rheumatol. 2024;51:130-133.
    PubMed     Abstract available


  24. KRISTENSEN S, Hagelskjaer AM, Cordtz R, Bliddal S, et al
    Polyautoimmunity in patients with anti-cyclic citrullinated peptide antibody-positive and -negative rheumatoid arthritis: a nationwide cohort study from Denmark.
    J Rheumatol. 2024 Feb 1:jrheum.2023-0907. doi: 10.3899/jrheum.2023-0907.
    PubMed     Abstract available


  25. GONZALEZ-GAY MA, Castaneda S, Ferraz-Amaro I
    Metabolic Syndrome: A Predisposing Factor for Rheumatoid Arthritis.
    J Rheumatol. 2024 Feb 1:jrheum.2023-1210. doi: 10.3899/jrheum.2023-1210.
    PubMed     Abstract available


  26. HEMGREN C, Martinsson K, Rooney C, Wettero J, et al
    Elevated Serum Levels of Zonulin Family Peptides in Anticitrullinated Protein Antibody-Positive At-Risk Individuals Without Arthritis.
    J Rheumatol. 2024;51:134-138.
    PubMed     Abstract available


  27. FARRER C, Thib S, Eder L, Jerome D, et al
    Use of Coordinator Role Improves Access to Rheumatologic Advanced Therapy.
    J Rheumatol. 2024;51:197-202.
    PubMed     Abstract available


    January 2024
  28. O'NEIL LJ, Alpizar-Rodriguez D, Deane KD
    Rheumatoid arthritis: The continuum of disease and strategies for prediction, early intervention and prevention.
    J Rheumatol. 2024 Jan 15:jrheum.2023-0334. doi: 10.3899/jrheum.2023-0334.
    PubMed     Abstract available


  29. STAMP LK, Keating P, Frampton C, Barclay ML, et al
    Relationship between adalimumab concentrations, anti-drug antibodies and disease activity in rheumatoid arthritis: a cross-sectional observational study.
    J Rheumatol. 2024 Jan 15:jrheum.2023-0706. doi: 10.3899/jrheum.2023-0706.
    PubMed     Abstract available


  30. LUO P, Xu W, Ye D, Chen W, et al
    Metabolic Syndrome Is Associated With an Increased Risk of Rheumatoid Arthritis: A Prospective Cohort Study Including 369,065 Participants.
    J Rheumatol. 2024 Jan 15:jrheum.2023-0349. doi: 10.3899/jrheum.2023-0349.
    PubMed     Abstract available


    December 2023
  31. ZHUO N, Wang G, Wu G
    The Incidence of Herpes Zoster Is Increased in the Population of Patients With Rheumatoid Arthritis.
    J Rheumatol. 2023 Dec 1:jrheum.2023-0249. doi: 10.3899/jrheum.2023-0249.
    PubMed     Abstract available


    November 2023
  32. POSIO C, Suardi I, Caporali R, Ingegnoli F, et al
    Owning Pets Reduces the Perception of Disease Activity in Patients With Rheumatoid Arthritis.
    J Rheumatol. 2023 Nov 15:jrheum.2023-0950. doi: 10.3899/jrheum.2023-0950.
    PubMed     Abstract available


  33. NOWELL WB, Barnes EL, Venkatachalam S, Kappelman MD, et al
    Racial and Ethnic Distribution of Rheumatic Diseases in Health Systems of the National Patient-Centered Clinical Research Network.
    J Rheumatol. 2023;50:1503-1508.
    PubMed     Abstract available


  34. MURAYAMA A
    Industry-Sponsored Research Funding to Rheumatologists in the United States Between 2014 and 2022.
    J Rheumatol. 2023;50:1510-1513.
    PubMed    


  35. INANC N, Jousse-Joulin S, Abacar K, Cimsit C, et al
    The novel OMERACT Ultrasound Scoring System for salivary glands changes in patients with Sjogren's syndrome is associated with MRI and salivary flow rates.
    J Rheumatol. 2023 Nov 1:jrheum.2023-0202. doi: 10.3899/jrheum.2023-0202.
    PubMed     Abstract available


    October 2023
  36. KWON HC, Kang MI, Kim SM
    Cystatin C as a Predictor of Renal function and Methotrexate-associated toxicities in Patients with Rheumatoid arthritis.
    J Rheumatol. 2023 Oct 1:jrheum.2023-0218. doi: 10.3899/jrheum.2023-0218.
    PubMed     Abstract available


  37. LEE JJY, Bernatsky S, Kwong JC, Li Q, et al
    Safety and Health Care Utilization following COVID-19 Vaccination among Adults with Rheumatoid Arthritis - A population-based self-controlled case series analysis.
    J Rheumatol. 2023 Oct 1:jrheum.2023-0355. doi: 10.3899/jrheum.2023-0355.
    PubMed     Abstract available


  38. KWOK TSH, Kuriya B, Eder L, Aghanya V, et al
    Low Nirmatrelvir/Ritonavir Use Among Patients With Rheumatoid Arthritis: A Signal of Concern.
    J Rheumatol. 2023 Oct 1:jrheum.2023-0439. doi: 10.3899/jrheum.2023-0439.
    PubMed     Abstract available


  39. CHANG YH, Buras MR, Davis JM 3rd, Crowson CS, et al
    Avoiding Blunders When Analyzing Correlated Data, Clustered Data, or Repeated Measures.
    J Rheumatol. 2023;50:1269-1272.
    PubMed     Abstract available


  40. ISLAM ST, Descallar J, Martens D, Hassett G, et al
    Screening for Anxiety in Patients With Inflammatory Arthritis Using the Multidimensional Health Assessment Questionnaire.
    J Rheumatol. 2023;50:1273-1278.
    PubMed     Abstract available


  41. SHRIDHARMURTHY D, Lapane KL, Nunes AP, Baek J, et al
    Postpartum Depression in Reproductive-Age Women With and Without Rheumatic Disease: A Population-Based Matched Cohort Study.
    J Rheumatol. 2023;50:1287-1295.
    PubMed     Abstract available


    September 2023
  42. BARTON JL
    Unequal Treatment: Physical Therapy Utilization in Rheumatoid Arthritis.
    J Rheumatol. 2023 Sep 15:jrheum.2023-0814. doi: 10.3899/jrheum.2023-0814.
    PubMed     Abstract available


  43. VISMAN I, Atiqi S, Boers M, Twisk J, et al
    Changes in TNF inhibitor drug survival in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis over 15 years.
    J Rheumatol. 2023 Sep 15:jrheum.2023-0149. doi: 10.3899/jrheum.2023-0149.
    PubMed     Abstract available


  44. BRYNJARSDOTTIR HB, Bjursten S, Levin M, Gjertsson I, et al
    Successful Management of Checkpoint Inhibitor-Induced Arthritis With Disease-Modifying Antirheumatic Drugs During Active Immune Checkpoint Inhibition Treatment.
    J Rheumatol. 2023;50:1195-1197.
    PubMed    


  45. YAMAMOTO K, Rokutanda R
    Disseminated Mycobacterium haemophilum Infection Mimicking Rheumatoid Nodules.
    J Rheumatol. 2023;50:1193.
    PubMed    


    August 2023
  46. HAZLEWOOD GS, Akhavan P, Pardo Pardo J, Agarwal A, et al
    Canadian Rheumatology Association Living Guidelines for Rheumatoid Arthritis: Update #1.
    J Rheumatol. 2023 Aug 1:jrheum.2023-0625. doi: 10.3899/jrheum.2023-0625.
    PubMed     Abstract available


  47. KAMEI R, Yamashita H, Kaneko H
    Clinical Characteristics and Predictors of the Recurrence of Organizing Pneumonia Associated with Rheumatoid Arthritis.
    J Rheumatol. 2023 Aug 1:jrheum.2023-0037. doi: 10.3899/jrheum.2023-0037.
    PubMed     Abstract available


  48. LANE CY, Lo D, Thoma LM, Zhang T, et al
    Sociocultural and Economic Disparities in Physical Therapy Utilization among Insured Older Adults with Rheumatoid Arthritis.
    J Rheumatol. 2023 Aug 1:jrheum.2023-0103. doi: 10.3899/jrheum.2023-0103.
    PubMed     Abstract available


    July 2023
  49. CHARLES-SCHOEMAN C, Hyde C, Guan S, Parikh N, et al
    Relationship Between Paraoxonase-1 Genotype and Activity, and Major Adverse Cardiovascular Events and Malignancies in Patients with Rheumatoid Arthritis Receiving Tofacitinib.
    J Rheumatol. 2023 Jul 15:jrheum.2023-0112. doi: 10.3899/jrheum.2023-0112.
    PubMed     Abstract available


  50. MOUSA J, Peterson MN, Crowson CS, Achenbach SJ, et al
    Validating the FRAX Score in a US Population-Based Study of Patients with Rheumatoid Arthritis.
    J Rheumatol. 2023 Jul 1:jrheum.2022-1293. doi: 10.3899/jrheum.2022-1293.
    PubMed     Abstract available


  51. WANG G, Liu Z
    The Relationship Between Red Cell Distribution Width, Absolute Lymphocyte Count, and Rheumatoid Arthritis.
    J Rheumatol. 2023 Jul 1:jrheum.2023-0321. doi: 10.3899/jrheum.2023-0321.
    PubMed     Abstract available


    June 2023
  52. CURRY PDK, Chinoy H, Jani M, Plant D, et al
    The Effect of COVID-19 on Medication Adherence in a Rheumatoid Arthritis (BRAGGSS) and Psoriatic Arthritis (OUTPASS) UK Cohort.
    J Rheumatol. 2023 Jun 15:jrheum.2022-1277. doi: 10.3899/jrheum.2022-1277.
    PubMed     Abstract available


  53. ALBAYRAK F, Koc E
    Rheumatoid Arthritis or Imitator?
    J Rheumatol. 2023 Jun 1:jrheum.2022-1253. doi: 10.3899/jrheum.2022-1253.
    PubMed     Abstract available


  54. BESSETTE L, Rahman P, Kelsall J, Purvis J, et al
    Incidence and Determinants of Infection in Rheumatoid Arthritis Patients Treated with Golimumab in Real-World After a Median Follow-up Time of 27 Months.
    J Rheumatol. 2023 Jun 1:jrheum.2022-1283. doi: 10.3899/jrheum.2022-1283.
    PubMed     Abstract available


  55. YAMAMOTO M, Fujita Y
    Bywaters Lesions: A Rare Cutaneous Vasculitis in Rheumatoid Arthritis.
    J Rheumatol. 2023 Jun 1:jrheum.2023-0169. doi: 10.3899/jrheum.2023-0169.
    PubMed     Abstract available


  56. HAROON M, Javed S, Ullah S, Hashmi F, et al
    Prevalence of Stress at Home and Its Significant Associations Among Patients With Rheumatoid Arthritis.
    J Rheumatol. 2023 Jun 1:jrheum.2023-0044. doi: 10.3899/jrheum.2023-0044.
    PubMed     Abstract available


  57. LIAO Z, Tian F, Yao F, Wen Z, et al
    Rheumatoid Vasculitis-Associated Foot Gangrene.
    J Rheumatol. 2023;50:845.
    PubMed    


    May 2023
  58. GREENE GJ, Beaumont JL, Bacalao EJ, Muftic A, et al
    Integrating PROMIS Measures in a Treat to Target (T2T) Approach to Standardize Patient-Centered Treatment of Rheumatoid Arthritis.
    J Rheumatol. 2023 May 1:jrheum.2022-1176. doi: 10.3899/jrheum.2022-1176.
    PubMed     Abstract available


    April 2023
  59. CURTIS JR, Emery P, Kricorian G, Yen PK, et al
    Factors Associated With Maintenance of Remission Following Change From Combination Therapy to Monotherapy in Patients With Rheumatoid Arthritis.
    J Rheumatol. 2023 Apr 15:jrheum.2022-1008. doi: 10.3899/jrheum.2022-1008.
    PubMed     Abstract available


  60. MCWILLIAMS DF, Walsh DA
    Inflammatory and Noninflammatory Disease Activity in Rheumatoid Arthritis: The Effect of Pain on Personalized Medicine.
    J Rheumatol. 2023 Apr 1:jrheum.230158. doi: 10.3899/jrheum.230158.
    PubMed     Abstract available


  61. VAN ONNA M, Boonen A
    Frailty in Inflammatory Arthritis: A Fragile Construct.
    J Rheumatol. 2023;50:463-465.
    PubMed    


  62. BARDAN I, Fagerli KM, Sexton J, Kvien TK, et al
    Treatment Response to Tumor Necrosis Factor Inhibitors and Methotrexate Monotherapy in Adults With Juvenile Idiopathic Arthritis: Data From NOR-DMARD.
    J Rheumatol. 2023;50:538-547.
    PubMed     Abstract available


    March 2023
  63. MYASOEDOVA E, Kurmann RD, Achenbach SJ, Wright K, et al
    Trends in incidence of chronic heart failure (HF) in patients with rheumatoid arthritis: a population-based study validating different HF definitions.
    J Rheumatol. 2023 Mar 15:jrheum.221170. doi: 10.3899/jrheum.221170.
    PubMed     Abstract available


    February 2023
  64. DAVTYAN A, Lee JJY, Eder L, Hawker GA, et al
    The Effects of Continuity of Rheumatology Care on Emergency Department Utilization and Hospitalizations for Individuals With Early Rheumatoid Arthritis: A Population-Based Study.
    J Rheumatol. 2023 Feb 1:jrheum.220996. doi: 10.3899/jrheum.220996.
    PubMed     Abstract available


  65. KAUR J, Cairns E, Barra L
    Restoring Balance: Immune Tolerance in Rheumatoid Arthritis.
    J Rheumatol. 2023 Feb 1:jrheum.220881. doi: 10.3899/jrheum.220881.
    PubMed     Abstract available


  66. SINGER D, Thompson-Leduc P, Poston S, Gupta D, et al
    Incidence of Herpes Zoster in Patients with Rheumatoid Arthritis in the United States: A Retrospective Cohort Study.
    J Rheumatol. 2023 Feb 1:jrheum.220986. doi: 10.3899/jrheum.220986.
    PubMed     Abstract available


  67. ITO Y, Nakahara H, Nakajima A
    Development of Pulmonary Alveolar Proteinosis in a Patient With Adult-Onset Still Disease Treated With Tocilizumab.
    J Rheumatol. 2023;50:288-289.
    PubMed    


  68. WENG J, Zhou LL, Hahn T, Shojania K, et al
    Adult-Onset Still Disease After ChAdOx1 nCOV-19 Vaccination.
    J Rheumatol. 2023;50:290-291.
    PubMed    


  69. MAICA GL, Iannaccone C, Feathers V, Frits ML, et al
    Understanding Differences in Patient Descriptions of Rheumatoid Arthritis Flares Using OMERACT Core Domains.
    J Rheumatol. 2023 Feb 1:jrheum.211409. doi: 10.3899/jrheum.211409.
    PubMed     Abstract available


    January 2023
  70. WOHLFAHRT A, Muhammad LF, Song J, Dunlop D, et al
    Pain Mechanisms Associated with Disease Activity in Patients with Rheumatoid Arthritis Treated with DMARDs: A Regression Tree Analysis.
    J Rheumatol. 2023 Jan 15:jrheum.220500. doi: 10.3899/jrheum.220500.
    PubMed     Abstract available


  71. BARBER CEH, Lacaille D, Croxford R, Barnabe C, et al
    Investigating Associations Between Access to Rheumatology Care, Treatment, Continuous Care, and Healthcare Utilization and Costs Among Older Individuals With Rheumatoid Arthritis.
    J Rheumatol. 2023 Jan 15:jrheum.220729. doi: 10.3899/jrheum.220729.
    PubMed     Abstract available


  72. COOK C, Patel NJ, Fu X, Wang X, et al
    Comparative effectiveness of BNT162b2 and mRNA-1273 vaccines against COVID-19 infection among patients with systemic autoimmune rheumatic diseases on immunomodulatory medications.
    J Rheumatol. 2023 Jan 15:jrheum.220870. doi: 10.3899/jrheum.220870.
    PubMed     Abstract available


  73. VIGNOS PJ JR, Parker WT, Thompson HM
    Evaluation of a Clinic Education Program for Patients with Rheumatoid Arthritis.
    J Rheumatol. 2023;50:156-165.
    PubMed     Abstract available


    December 2022
  74. GORZEWSKI AM, Heisler AC, Neogi T, Muhammad LN, et al
    Predicting Disease Activity in Rheumatoid Arthritis with the Fibromyalgia Survey Questionnaire: Does the Severity of Fibromyalgia Symptoms Matter?
    J Rheumatol. 2022 Dec 15:jrheum.220507. doi: 10.3899/jrheum.220507.
    PubMed     Abstract available


    November 2022
  75. WANG G, Zhuo N, Wen Z
    Clinically Active Rheumatoid Arthritis and the Presence of Cardiovascular Disease Are Associated With an Elevated Risk of Dementia Incidence.
    J Rheumatol. 2022 Nov 15. pii: jrheum.220934. doi: 10.3899/jrheum.220934.
    PubMed     Abstract available


  76. KLOSE-JENSEN R, Therkildsen J, Blavnsfeldt AG, Langdah B, et al
    The minimal erosive volume needed for radiographic identification of erosions in the metacarpophalangeal joints in patients with rheumatoid arthritis.
    J Rheumatol. 2022 Nov 15. pii: jrheum.220623. doi: 10.3899/jrheum.220623.
    PubMed     Abstract available


  77. DUMOULIN QA, Verstappen M, van der Helm van Mil AHM, van Steenbergen HW, et al
    Joint Damage Over Time in Patients With Early Rheumatoid Arthritis Follows Trajectories Related to Distinct Courses of Disease Activity.
    J Rheumatol. 2022 Nov 1. pii: jrheum.220531. doi: 10.3899/jrheum.220531.
    PubMed     Abstract available


  78. LANGE A, Kostadinova L, Damjanovska S, Gad I, et al
    Red Cell Distribution Width and Absolute Lymphocyte Count Associate with Biomarkers of Inflammation and Subsequent Mortality in Rheumatoid Arthritis.
    J Rheumatol. 2022 Nov 1. pii: jrheum.211411. doi: 10.3899/jrheum.211411.
    PubMed     Abstract available


  79. TAKANASHI S, Takeuchi T, Kaneko Y
    Impacts of ageing on rheumatoid factor and anti-cyclic citrullinated peptide antibody positivity in patients with rheumatoid arthritis.
    J Rheumatol. 2022 Nov 1. pii: jrheum.220526. doi: 10.3899/jrheum.220526.
    PubMed     Abstract available


  80. SATTUI SE, Lieber SB
    Keep It in Mind: Assessing the Risk of Dementia in Patients With Rheumatoid Arthritis and Opportunities for Intervention.
    J Rheumatol. 2022 Nov 1. pii: jrheum.220991. doi: 10.3899/jrheum.220991.
    PubMed     Abstract available


  81. TAYLOR PC
    The Opportunities and Challenges of Telemedicine in the Management of People With Rheumatoid Arthritis.
    J Rheumatol. 2022;49:1188-1190.
    PubMed    


    October 2022
  82. TCHETINA EV
    Baseline Gene Expression Analysis in the Peripheral Blood of Patients With Rheumatoid Arthritis as an Important Supplement to Standard Composite Measure.
    J Rheumatol. 2022 Oct 15. pii: jrheum.220795. doi: 10.3899/jrheum.220795.
    PubMed     Abstract available


  83. ISNARDI CA, Cerda OL, Landi M, Cruces L, et al
    Immune Response to SARS-CoV-2 Third Vaccine in Patients With Rheumatoid Arthritis Who Had No Seroconversion After Primary 2-Dose Regimen With Inactivated or Vector-Based Vaccines.
    J Rheumatol. 2022 Oct 1. pii: jrheum.220469. doi: 10.3899/jrheum.220469.
    PubMed     Abstract available


  84. GLINTBORG B, Jensen DV, Terslev L, Hendricks O, et al
    Long-term Behavioral Changes During the COVID-19 Pandemic and Impact of Vaccination in Patients With Inflammatory Rheumatic Diseases.
    J Rheumatol. 2022;49:1163-1172.
    PubMed     Abstract available


    September 2022
  85. DESSEIN PH, Stanwix AE, Solomon A
    How Could Physical Activity Reduce Inflammation and Inflammatory Gene Expression in Rheumatoid Arthritis?
    J Rheumatol. 2022 Sep 15. pii: jrheum.220788. doi: 10.3899/jrheum.220788.
    PubMed     Abstract available


  86. VAN DIJK B, van der Helm-van Mil A
    Delayed Referral of Female Patients With Rheumatoid Arthritis: Where Are We Now? A Study Spanning 3 Decades.
    J Rheumatol. 2022 Sep 15. pii: jrheum.220429. doi: 10.3899/jrheum.220429.
    PubMed     Abstract available


  87. FAYET F, Darmant N, Rodere M, Fan A, et al
    The Practice of Argentine Tango in Patients With Rheumatoid Arthritis and Spondyloarthritis: A Qualitative Study, a Positive Experience.
    J Rheumatol. 2022 Sep 15. pii: jrheum.220103. doi: 10.3899/jrheum.220103.
    PubMed     Abstract available


  88. PENABAD IC
    The Prism of Inequity: Health Disparities in Rheumatoid Arthritis.
    J Rheumatol. 2022;49:1070-1071.
    PubMed    


  89. VENKATACHALAM S, Nowell WB
    Taking the Long View: Patients Perceive Benefits and Risks of Treatment as Multidimensional.
    J Rheumatol. 2022;49:971-973.
    PubMed    


    August 2022
  90. FERRAZ-AMARO I, Sheikh A, Polack B, Giles JT, et al
    Articular (18)Fluorodeoxyglucose Uptake Is Associated with Clinically Assessed Swollen Joint Count in Patients with Rheumatoid Arthritis.
    J Rheumatol. 2022 Aug 15. pii: jrheum.220231. doi: 10.3899/jrheum.220231.
    PubMed     Abstract available


  91. MENG CF, Rajesh DA, Jannat-Khah DP, Jivanelli B, et al
    Can Patients with Controlled Rheumatoid Arthritis Taper Methotrexate from Targeted Therapy and Sustain Remission? A Systematic Review and Meta-analysis.
    J Rheumatol. 2022 Aug 15. pii: jrheum.220152. doi: 10.3899/jrheum.220152.
    PubMed     Abstract available


  92. BAGGETT K, Brandon TG, Xiao R, Valenzuela Z, et al
    Incidence Rates of Psoriasis in Children With Inflammatory Bowel Disease and Juvenile Arthritis Treated With Tumor Necrosis Factor Inhibitors and Disease-Modifying Antirheumatic Drugs.
    J Rheumatol. 2022;49:935-941.
    PubMed     Abstract available


    July 2022
  93. HAZLEWOOD GS, Pardo JP, Barnabe C, Schieir O, et al
    Canadian Rheumatology Association living guidelines for the pharmacological management of rheumatoid arthritis with disease-modifying anti-rheumatic drugs.
    J Rheumatol. 2022 Jul 15. pii: jrheum.220209. doi: 10.3899/jrheum.220209.
    PubMed     Abstract available


  94. KODISHALA C, Hulshizer CA, Kronzer VL, Davis JM 3rd, et al
    Risk Factors for Dementia in Patients with Incident Rheumatoid Arthritis: A Population-based Cohort Study.
    J Rheumatol. 2022 Jul 15. pii: jrheum.220200. doi: 10.3899/jrheum.220200.
    PubMed     Abstract available


  95. PATTERSON SL, Sun S, Rychkov D, Katz P, et al
    Physical Activity Associates with Lower Systemic Inflammatory Gene Expression in Rheumatoid Arthritis.
    J Rheumatol. 2022 Jul 1. pii: jrheum.220050. doi: 10.3899/jrheum.220050.
    PubMed     Abstract available


    June 2022
  96. DAVIS JM 3RD
    The Patient Experience of Drug Side Effects in Rheumatoid Arthritis: Intriguing Data From an Exploratory Online Survey.
    J Rheumatol. 2022 Jun 15. pii: jrheum.220412. doi: 10.3899/jrheum.220412.
    PubMed     Abstract available


  97. AVOUAC J, Molto A, Frantz C, Wanono S, et al
    Evaluation of patients with rheumatoid arthritis in teleconsultation during the first wave of the COVID-19 pandemic.
    J Rheumatol. 2022 Jun 15. pii: jrheum.220073. doi: 10.3899/jrheum.220073.
    PubMed     Abstract available


  98. MOORE MN, Wallace BI, Song J, Muhammad LN, et al
    Correlation of fibromyalgia survey questionnaire and quantitative sensory testing among patients with active rheumatoid arthritis.
    J Rheumatol. 2022 Jun 1. pii: jrheum.220046. doi: 10.3899/jrheum.220046.
    PubMed     Abstract available


  99. DARABIAN S, Wade JP, Kur J, Wade SD, et al
    Using FibroScan to Assess for the Development of Liver Fibrosis in Patients With Arthritis on Methotrexate: A Single-center Experience.
    J Rheumatol. 2022;49:558-565.
    PubMed     Abstract available


  100. NASH P
    Janus Kinase Inhibitors: Safety in Patients With Psoriatic Arthritis.
    J Rheumatol. 2022;49.
    PubMed     Abstract available


  101. BESSETTE L, Mysler E, Kinch CD, Kwok K, et al
    Impact of Tofacitinib on Components of the ACR Response Criteria: Post Hoc Analysis of Phase III and Phase IIIb/IV Trials.
    J Rheumatol. 2022;49:566-576.
    PubMed     Abstract available


  102. LUBBERTS E, Scher JU, FitzGerald O
    Basic Science Session 2. Recent Advances in Our Understanding of Psoriatic Arthritis Pathogenesis.
    J Rheumatol. 2022;49.
    PubMed     Abstract available


    May 2022
  103. CAGNOTTO G, Jacobsson THL, Rydell E, Eberhard A, et al
    Male Sex Predicts a Favorable Outcome in Early ACPA-negative Rheumatoid Arthritis: Data From An Observational Study.
    J Rheumatol. 2022 May 2. pii: jrheum.211199. doi: 10.3899/jrheum.211199.
    PubMed     Abstract available


  104. DIRENZO DD, Robinson S, Bingham CO 3rd, Baer AN, et al
    PROMIS Provides a Broader Overview of Health-related Quality of Life Than the ESSPRI in Evaluation of Sjogren Syndrome.
    J Rheumatol. 2022;49:470-474.
    PubMed     Abstract available


  105. EDER L, Croxford R, Drucker AM, Mendel A, et al
    COVID-19 Hospitalizations, Intensive Care Unit Stays, Ventilation, and Death Among Patients With Immune-mediated Inflammatory Diseases Compared to Controls.
    J Rheumatol. 2022;49:523-530.
    PubMed     Abstract available


  106. WIDDIFIELD J, Eder L, Chen S, Kwong JC, et al
    COVID-19 Vaccination Uptake Among Individuals With Immune-mediated Inflammatory Diseases in Ontario, Canada, Between December 2020 and October 2021: A Population-based Analysis.
    J Rheumatol. 2022;49:531-536.
    PubMed     Abstract available


    April 2022
  107. LIAO PY, Liao SL, Liaw YP
    Extraarticular Manifestations and Comorbidities in Patients With Rheumatoid Arthritis.
    J Rheumatol. 2022 Apr 15. pii: jrheum.211278. doi: 10.3899/jrheum.211278.
    PubMed     Abstract available


  108. VERWEIJ NJF, de Jongh J, Ter Wee MM, Zwezerijnen GJC, et al
    Whole body macrophage PET imaging for disease activity assessment in early rheumatoid arthritis.
    J Rheumatol. 2022 Apr 15. pii: jrheum.210928. doi: 10.3899/jrheum.210928.
    PubMed     Abstract available


  109. ZICKUHR L, Mandell BF
    Rheumatology Education Needs a Splash of Color.
    J Rheumatol. 2022;49:343-345.
    PubMed    


    March 2022
  110. MCDERMOTT G, Gill R, Gagne S, Byrne S, et al
    Demographic, Lifestyle, and Serologic Risk Factors for Rheumatoid Arthritis-Associated Bronchiectasis: Role of RA-related Autoantibodies.
    J Rheumatol. 2022 Mar 15. pii: jrheum.211242. doi: 10.3899/jrheum.211242.
    PubMed     Abstract available


  111. HADWEN B, Yu R, Cairns E, Barra L, et al
    Presence of Autoantibodies in Males and Females with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.
    J Rheumatol. 2022 Mar 15. pii: jrheum.211020. doi: 10.3899/jrheum.211020.
    PubMed     Abstract available


  112. YAZDANYAR A, Donato A, Wasko MC, Ward MM, et al
    Risk of 30-day Readmission After Knee or Hip Replacement in Rheumatoid Arthritis and Osteoarthritis by Non-Medicare and Medicare Payer Status.
    J Rheumatol. 2022;49:340.
    PubMed    


  113. HAZLEWOOD GS, Schieir O, Bykerk V, Mujaab K, et al
    Frequency of symptomatic adverse events in rheumatoid arthritis: an exploratory online survey.
    J Rheumatol. 2022 Mar 1. pii: jrheum.210688. doi: 10.3899/jrheum.210688.
    PubMed     Abstract available


  114. KREMER JM, Reed G, Pappas DA, Kane K, et al
    Dr. Kremer et al reply.
    J Rheumatol. 2022;49:338-339.
    PubMed    


    February 2022
  115. MOVAHEDI M, Cesta A, Li X, Keystone EC, et al
    Physician and Patient Reported Effectiveness are similar for Tofacitinib and TNFi in Rheumatoid Arthritis: Data from a Rheumatoid Arthritis Registry.
    J Rheumatol. 2022 Feb 15. pii: jrheum.211066. doi: 10.3899/jrheum.211066.
    PubMed     Abstract available


  116. LE MOINE C, Soyfoo MS, Mekkaoui L, Dahma H, et al
    Impaired humoral immunogenicity of SARS-CoV-2 vaccination in rheumatoid arthritis patients.
    J Rheumatol. 2022 Feb 1. pii: jrheum.211270. doi: 10.3899/jrheum.211270.
    PubMed     Abstract available


  117. DE ANGELIS R, Giuggioli D, Bajocchi G, Dagna L, et al
    Sex-related Differences in Systemic Sclerosis: A Multicenter Cross-sectional Study From the National Registry of the Italian Society for Rheumatology.
    J Rheumatol. 2022;49:176-185.
    PubMed     Abstract available


  118. BERARDICURTI O, Pavlych V, Cola ID, Ruscitti P, et al
    Long-term Safety of Rituximab in Primary Sjogren Syndrome: The Experience of a Single Center.
    J Rheumatol. 2022;49:171-175.
    PubMed     Abstract available


  119. KAWADA T
    Smoking, Obesity, and Risk of Primary Sjogren Syndrome.
    J Rheumatol. 2022;49:234.
    PubMed    


  120. BERTI A, Cornec D, Crowson CS, Matteson EL, et al
    Dr. Berti et al reply.
    J Rheumatol. 2022;49:234.
    PubMed    


  121. GRIFFITHS H, Smith T, Mack C, Leadbetter J, et al
    Persistence to Biologic Therapy Among Patients With Ankylosing Spondylitis: An Observational Study Using the OPAL Dataset.
    J Rheumatol. 2022;49:150-156.
    PubMed     Abstract available


    January 2022
  122. PAZMINO S, Lovik A, Westhovens R, Verschueren P, et al
    Evaluation of Disease Burden by (Separate) Patient-reported, Clinical, and Laboratory Factor Scores in Patients With Established Rheumatoid Arthritis: A Factor Analysis Replication.
    J Rheumatol. 2022 Jan 15. pii: jrheum.210871. doi: 10.3899/jrheum.210871.
    PubMed     Abstract available


  123. BREDEMEIER M, Ranza R, Kakehasi AM, Ranzolin A, et al
    Safety of the Methotrexate-leflunomide Combination in Rheumatoid Arthritis: Results of a Multicentric, Registry-based, Cohort Study (BiobadaBrasil).
    J Rheumatol. 2022;49:122.
    PubMed    


    December 2021
  124. KREMER JM, Pappas DA, Kane K, Greenberg J, et al
    The Clinical Disease Activity Index and the Routine Assessment of Patient Index Data 3 for Achievement of Treatment Strategies.
    J Rheumatol. 2021;48:1776-1783.
    PubMed     Abstract available


    November 2021
  125. WIENS D, Smolik I, Meng X, Anaparti V, et al
    Functional disability to evaluate the risk of arthritis in First-degree relatives of Rheumatoid Arthritis patients.
    J Rheumatol. 2021 Nov 1. pii: jrheum.210614. doi: 10.3899/jrheum.210614.
    PubMed     Abstract available


  126. AGUIRRE A, Yazdany J
    Hepatitis B Screening Before Biologic or Targeted Synthetic Disease-modifying Antirheumatic Drug Therapy: Many Roads to Improvement.
    J Rheumatol. 2021 Nov 1. pii: jrheum.211000. doi: 10.3899/jrheum.211000.
    PubMed     Abstract available


    October 2021
  127. PINCUS T, Bergman MJ, Yazici Y
    Should Quantitative Measures and Management of Rheumatoid Arthritis Include More Than Control of Inflammatory Activity?
    J Rheumatol. 2021 Oct 15. pii: jrheum.210953. doi: 10.3899/jrheum.210953.
    PubMed     Abstract available


  128. KRONZER VL, Huang W, Zaccardelli A, Crowson CS, et al
    Association of sinusitis and upper respiratory tract diseases with incident rheumatoid arthritis: A case-control study.
    J Rheumatol. 2021 Oct 15. pii: jrheum.210580. doi: 10.3899/jrheum.210580.
    PubMed     Abstract available


  129. STUDENIC P, Radner H
    Back to Basics: Prioritizing Communication as a Key Instrument in Managing Rheumatoid Arthritis.
    J Rheumatol. 2021 Oct 1. pii: jrheum.210984. doi: 10.3899/jrheum.210984.
    PubMed     Abstract available


  130. YAZDANYAR A, Donato A, Wasko MC, Ward MM, et al
    Risk of 30-day Readmission after Knee or Hip Replacement in Rheumatoid Arthritis and Osteoarthritis by non-Medicare and Medicare Payer Status.
    J Rheumatol. 2021 Oct 1. pii: jrheum.201370. doi: 10.3899/jrheum.201370.
    PubMed     Abstract available


  131. CHATZIDIONYSIOU K, Hetland ML, Frisell T, Di Giuseppe D, et al
    Effectiveness of a Second Biologic After Failure of a Non-tumor Necrosis Factor Inhibitor As First Biologic in Rheumatoid Arthritis.
    J Rheumatol. 2021;48:1512-1518.
    PubMed     Abstract available


  132. SAFY-KHAN M, de Hair MJH, Welsing PMJ, van Laar JM, et al
    Current Smoking Negatively Affects the Response to Methotrexate in Rheumatoid Arthritis in a Dose-responsive Way, Independently of Concomitant Prednisone Use.
    J Rheumatol. 2021;48:1504-1507.
    PubMed     Abstract available


    September 2021
  133. VAN DER HEIJDE D, Kartman CE, Xie L, Beattie S, et al
    Radiographic progression of structural joint damage over 5 years of baricitinib treatment in patients with rheumatoid arthritis: Results from RA-BEYOND.
    J Rheumatol. 2021 Sep 15. pii: jrheum.210346. doi: 10.3899/jrheum.210346.
    PubMed     Abstract available


  134. FERNANDES BM, Pereira JM, Pereira PR, Bernardes M, et al
    Tuberculosis Presenting as an Inflammatory Pseudotumor of the Sciatic Nerve in a Rheumatoid Arthritis Patient Taking Etanercept.
    J Rheumatol. 2021 Sep 15. pii: jrheum.210540. doi: 10.3899/jrheum.210540.
    PubMed     Abstract available


  135. VAN WEELY SFE
    The Reproducibility of Patient Self-reported Joint Counts in Rheumatoid Arthritis: A Closer Look at the Results of a Review.
    J Rheumatol. 2021 Sep 1. pii: jrheum.210822. doi: 10.3899/jrheum.210822.
    PubMed     Abstract available


  136. BEKKER CL, Bossina S, de Vera MA, Bartlett SJ, et al
    Patient Perspectives on Outcome Domains of Medication Adherence Trials in Inflammatory Arthritis: An International OMERACT Focus Group Study.
    J Rheumatol. 2021;48:1480-1487.
    PubMed     Abstract available


    August 2021
  137. WANG X, Hefton A, Ni K, Ukadike KC, et al
    Autoantibodies against unmodified and citrullinated human endogenous retrovirus K envelope protein in rheumatoid arthritis patients.
    J Rheumatol. 2021 Aug 1. pii: jrheum.201492. doi: 10.3899/jrheum.201492.
    PubMed     Abstract available


  138. MEER E, Thrastardottir T, Wang X, Dubreuil M, et al
    Risk factors for diagnosis of psoriatic arthritis, psoriasis, rheumatoid arthritis, and ankylosing spondylitis: A set of parallel case-control studies.
    J Rheumatol. 2021 Aug 1. pii: jrheum.210006. doi: 10.3899/jrheum.210006.
    PubMed     Abstract available


  139. HAZLEWOOD GS, Bombardier C, Li X, Movahedi M, et al
    Heterogeneity in patient characteristics and differences in treatment across four Canadian rheumatoid arthritis cohorts.
    J Rheumatol. 2021 Aug 1. pii: jrheum.201688. doi: 10.3899/jrheum.201688.
    PubMed     Abstract available


  140. CHEN YW, Tsai PY, Wei JC
    Lymphoma and Sjogren Syndrome: A Common Overlapping Syndrome?
    J Rheumatol. 2021;48:1343.
    PubMed    


  141. RIPSMAN DA, Bookman AAM
    Correlation Between Subjective and Objective Severity of Oral and Ocular Dryness in Primary Sjogren Syndrome.
    J Rheumatol. 2021;48:1290-1294.
    PubMed     Abstract available


  142. BEAUMONT JL, Davis ES, Curtis JR, Cella D, et al
    Meaningful Change Thresholds for Patient-Reported Outcomes Measurement Information System (PROMIS) Fatigue and Pain Interference Scores in Patients With Rheumatoid Arthritis.
    J Rheumatol. 2021;48:1239-1242.
    PubMed     Abstract available


  143. VU M, Carvalho N, Clarke PM, Buchbinder R, et al
    Impact of Comorbid Conditions on Healthcare Expenditure and Work-related Outcomes in Patients With Rheumatoid Arthritis.
    J Rheumatol. 2021;48:1221-1229.
    PubMed     Abstract available


  144. BOERS M, Pincus T
    Long-term Glucocorticoid Use in Rheumatoid Arthritis.
    J Rheumatol. 2021;48:1342.
    PubMed    


    July 2021
  145. KAHLER J, Mastarone G, Matsumoto R, ZuZero D, et al
    It may help you to know. . .": The early phase qualitative development of a rheumatoid arthritis goal elicitation tool.
    J Rheumatol. 2021 Jul 1. pii: jrheum.201615. doi: 10.3899/jrheum.201615.
    PubMed     Abstract available


  146. JARROT PA, Arcani R, Darmon O, Roudier J, et al
    Axial Articular Manifestations in Primary Sjogren Syndrome: Association With Spondyloarthritis.
    J Rheumatol. 2021;48:1037-1046.
    PubMed     Abstract available


  147. ORNETTI P, Guillier D, Jeudy G
    Perforating Rheumatoid Nodule Mimicking Malignant Soft-tissue Mass of the Forearm.
    J Rheumatol. 2021;48:1103.
    PubMed    


  148. YUN H, Xie F, Chen L, Yang S, et al
    Evaluation of the Effect of Diabetes on Rheumatoid Arthritis-related Outcomes in an Electronic Health Record-based Rheumatology Registry.
    J Rheumatol. 2021;48:992-1001.
    PubMed     Abstract available


  149. MCCOY SS, Bartels CM, Saldanha IJ, Bunya VY, et al
    National Sjogren's Foundation Survey: Burden of Oral and Systemic Involvement on Quality of Life.
    J Rheumatol. 2021;48:1029-1036.
    PubMed     Abstract available


  150. FOX RI, Fox CM
    Axial Articular Manifestations in Primary Sjogren Syndrome: Have We Been Missing Spondyloarthritis for All This Time?
    J Rheumatol. 2021;48:963-964.
    PubMed    


  151. HANLY JG, Lethbridge L
    Use of Disease-modifying Antirheumatic Drugs, Biologics, and Corticosteroids in Older Patients With Rheumatoid Arthritis Over 20 Years.
    J Rheumatol. 2021;48:977-984.
    PubMed     Abstract available


    June 2021
  152. BATHON JM
    Is the Gap in Incidence of Cardiovascular Events in Rheumatoid Arthritis Really Closing?
    J Rheumatol. 2021 Jun 15. pii: jrheum.210366. doi: 10.3899/jrheum.210366.
    PubMed     Abstract available


  153. JANSEN G, de Rotte MCFJ, de Jonge R
    Smoking and Methotrexate Inefficacy in Rheumatoid Arthritis: What About Underlying Molecular Mechanisms?
    J Rheumatol. 2021 Jun 15. pii: jrheum.210217. doi: 10.3899/jrheum.210217.
    PubMed     Abstract available


  154. GOULIELMOS GN, Zervou MI
    Risk of Venous Thromboembolism in Ankylosing Spondylitis and Rheumatoid Arthritis: Genetic Aspects.
    J Rheumatol. 2021 Jun 15. pii: jrheum.210131. doi: 10.3899/jrheum.210131.
    PubMed     Abstract available


  155. FERREIRA RJO, Landewe RBM, da Silva JAP
    Definition of Treatment Targets in Rheumatoid Arthritis: Is It Time for Reappraisal?
    J Rheumatol. 2021 Jun 1. pii: jrheum.210050. doi: 10.3899/jrheum.210050.
    PubMed     Abstract available


  156. SPARKS JA
    Multimorbidity Accrual After Incident Rheumatoid Arthritis: A Wolf at the Door.
    J Rheumatol. 2021 Jun 1. pii: jrheum.210224. doi: 10.3899/jrheum.210224.
    PubMed     Abstract available


  157. MARKOUSIS-MAVROGENIS G, Mavrogeni SI
    Cutting the "Gordian Knot" - Cardiac Involvement in Primary Sjogren Syndrome.
    J Rheumatol. 2021;48:802-803.
    PubMed    


  158. LINDBERG H, Colliander C, Nise L, Dahlqvist J, et al
    Are Farming and Animal Exposure Risk Factors for the Development of Granulomatosis With Polyangiitis? Environmental Risk Factors Revisited: A Case-control Study.
    J Rheumatol. 2021;48:894-897.
    PubMed     Abstract available


  159. NISHIWAKI A, Kobayashi H, Ikumi N, Kobayashi Y, et al
    Salivary Gland Focus Score Is Associated With Myocardial Fibrosis in Primary Sjogren Syndrome Assessed by a Cardiac Magnetic Resonance Approach.
    J Rheumatol. 2021;48:859-866.
    PubMed     Abstract available


    May 2021
  160. JACOBS JWG, Verhoeven MMA, Welsing PMJ
    Unravelling the Cost of Biological Strategies in Rheumatoid Arthritis: A Kaleidoscope of Methodologies, Interpretations, and Interests.
    J Rheumatol. 2021 May 15. pii: jrheum.201510. doi: 10.3899/jrheum.201510.
    PubMed     Abstract available


  161. PIANAROSA E, Hazlewood G, Thomas M, Hsiao R, et al
    Supporting Equity in Rheumatoid Arthritis Outcomes in Canada: Population-Specific Factors in Patient-Centered Care.
    J Rheumatol. 2021 May 15. pii: jrheum.210016. doi: 10.3899/jrheum.210016.
    PubMed     Abstract available


  162. RAMPES S, Patel V, Bosworth A, Jacklin C, et al
    Systematic review and meta-analysis of the reproducibility of patient self-reported joint counts in rheumatoid arthritis.
    J Rheumatol. 2021 May 15. pii: jrheum.201439. doi: 10.3899/jrheum.201439.
    PubMed     Abstract available


  163. TANIGUCHI Y, Kimata T
    Yellow Nail Syndrome Associated With Rheumatoid Arthritis.
    J Rheumatol. 2021;48:785.
    PubMed    


  164. BREDEMEIER M, Ranza R, Kakehasi AM, Ranzolin A, et al
    Safety of the Methotrexate-leflunomide Combination in Rheumatoid Arthritis: Results of a Multicentric, Registry-based, Cohort Study (Biobadabrasil).
    J Rheumatol. 2021 May 1. pii: jrheum.201248. doi: 10.3899/jrheum.201248.
    PubMed     Abstract available


  165. JOHANSSON FD, Collins JE, Yau V, Guan H, et al
    Predicting Response to Tocilizumab Monotherapy in Rheumatoid Arthritis: A Real-World Data Analysis Using Machine Learning.
    J Rheumatol. 2021 May 1. pii: jrheum.201626. doi: 10.3899/jrheum.201626.
    PubMed     Abstract available


  166. LIU Y, Zhang S, Xia CS, Chen J, et al
    Elevated Granulocyte Colony-stimulating Factor Levels in Patients With Active Phase of Adult-onset Still Disease.
    J Rheumatol. 2021;48:664-668.
    PubMed     Abstract available


    April 2021
  167. TANAKA Y, Takeuchi T, Soen S, Yamanaka H, et al
    Effects of denosumab in Japanese rheumatoid arthritis patients treated with conventional anti-rheumatic drugs: 36-month extension of a phase 3 study.
    J Rheumatol. 2021 Apr 15. pii: jrheum.201376. doi: 10.3899/jrheum.201376.
    PubMed     Abstract available


  168. KARLSSON SUNDBAUM J, Arkema EV, Bruchfeld J, Jonsson J, et al
    Tuberculosis in biologic-naive patients with rheumatoid arthritis - risk factors and tuberculosis characteristics.
    J Rheumatol. 2021 Apr 1. pii: jrheum.201251. doi: 10.3899/jrheum.201251.
    PubMed     Abstract available


  169. LIANG YT, Leong PY, Wei JC
    Questions on the Bidirectional Relationship Between Primary Sjogren Syndrome and Non-Hodgkin Lymphoma.
    J Rheumatol. 2021;48:620.
    PubMed    


    March 2021
  170. DEVAUCHELLE-PENSEC V
    Ultrasonography of the Salivary Gland in Primary Sjogren Syndrome: Usefulness to Phenotype the Patients.
    J Rheumatol. 2021 Mar 1. pii: jrheum.201433. doi: 10.3899/jrheum.201433.
    PubMed     Abstract available


    January 2021
  171. PANCHOVSKA M
    Questions From Patients and Doctors on Negative Minor Salivary Gland Biopsy in Sjogren Syndrome.
    J Rheumatol. 2021;48:149.
    PubMed    


  172. MONSALVE DM, Anaya JM
    Drs. Monsalve and Anaya reply.
    J Rheumatol. 2021;48:149.
    PubMed    


    October 2020
  173. MOSSEL E, van Nimwegen JF, Stel AJ, Wijnsma RF, et al
    Clinical phenotyping of primary Sjogren's patients using salivary gland ultrasonography - data from the RESULT cohort.
    J Rheumatol. 2020 Oct 1. pii: jrheum.200482. doi: 10.3899/jrheum.200482.
    PubMed     Abstract available


    August 2020
  174. GROSSE J, Allado E, Albuisson E, Pierreisnard A, et al
    The USSe (UltraSound Score for Erosions) in the evaluation of bone erosions in RA compared to the SHSe (Van der Heijde-modified Sharp score for erosions).
    J Rheumatol. 2020 Aug 15. pii: jrheum.200286. doi: 10.3899/jrheum.200286.
    PubMed     Abstract available


    May 2020
  175. SAHINKAYA Y, Mumcu G, Ozdemir FT, Kurus RE, et al
    Are Salivary Gland Ultrasonography Scores Associated with Salivary Flow Rates and Oral Health Related Quality of Life in Sjogren's syndrome?
    J Rheumatol. 2020 May 1. pii: jrheum.190849. doi: 10.3899/jrheum.190849.
    PubMed     Abstract available


    February 2020
  176. WARD JM, Hess JN, Davis LS
    Targetoid-like Lesions in the Setting of Systemic Lupus Erythematosus: A Case of Rowell Syndrome.
    J Rheumatol. 2020;47:298-299.
    PubMed    


    September 2019
  177. RUACHO G, Kvarnstrom M, Zickert A, Oke V, et al
    Sjogren's syndrome in Systemic Lupus Erythematosus - a subset characterized by a systemic inflammatory state.
    J Rheumatol. 2019 Sep 15. pii: jrheum.190250. doi: 10.3899/jrheum.190250.
    PubMed     Abstract available


    August 2019
  178. RENNER N, Kleyer A, Kronke G, Simon D, et al
    T2 Mapping as a New Method for Quantitative Assessment of Cartilage Damage in RA.
    J Rheumatol. 2019 Aug 15. pii: jrheum.180728. doi: 10.3899/jrheum.180728.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.